SCHEMBL9301181

SCHEMBL9301181

Nc1cccc(S(=O)(=O)Nc2nccs2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.69
LMNA P02545 2/20 0.69
KDM4E B2RXH2 1/20 0.69
CYP2C9 P11712 1/20 0.69
EDNRA P25101 1/20 0.69
SLC6A4 P31645 1/20 0.69
ADRA1A P35348 1/20 0.69
PRMT6 Q96LA8 1/20 0.69
TDP1 Q9NUW8 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.57
PKM P14618 5/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
POLB P06746 1/20 0.54
CYP1A2 P05177 1/20 0.52
ATM Q13315 1/20 0.52
DNMT1 P26358 1/20 0.52
SCN8A Q9UQD0 4/20 0.51
SCN1B Q07699 3/20 0.51
SCN1A P35498 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1094871 0.83 ALDH1A1 (0.57) ALDH1A1LMNAKDM4ECYP2C9EDNRA
SCHEMBL1576750 0.83 ALDH1A1 (0.57) ALDH1A1LMNAKDM4ECYP2C9EDNRA
SCHEMBL13230136 0.83 PKM (0.60) ALDH1A1LMNAKDM4ECYP2C9EDNRA
SCHEMBL19613863 0.83 LMNA (0.69) ALDH1A1LMNAKDM4ECYP2C9EDNRA
Sulfathiazole SCHEMBL30130508 0.82 ALDH1A1 (1.00) ALDH1A1LMNAKDM4ECYP2C9EDNRA
Sulfathiazole SCHEMBL94165 0.82 ALDH1A1 (1.00) ALDH1A1LMNAKDM4ECYP2C9EDNRA
SCHEMBL326633 0.82 ALDH1A1 (0.71) ALDH1A1LMNAKDM4ECYP2C9EDNRA
SCHEMBL1095177 0.81 ALDH1A1 (0.56) ALDH1A1LMNAKDM4ECYP2C9EDNRA
Sulfathiazole SCHEMBL18425505 0.81 ALDH1A1 (0.97) ALDH1A1LMNAKDM4ECYP2C9EDNRA
Sulfathiazole SCHEMBL468436 0.81 ALDH1A1 (0.97) ALDH1A1LMNAKDM4ECYP2C9EDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118317956-A Bis (hetero) aryl thioether oxadiazines as fungicidal compounds 拜耳公司 2024-07-09 CN disclosed
CN-116057056-A Azabicyclo-substituted heterocyclic compounds as fungicides 拜耳公司 2023-05-02 CN disclosed
CN-115803317-A Azabicyclo (thio) amides as fungicidal compounds 拜耳作物科学股份公司 2023-03-14 CN disclosed
WO-2017156181-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-09-14 WO disclosed
US-20140357655-A1 SPIROINDOLINE DERIVATIVES AS GONADOTROPIN- RELEASING HORMONE RECEPTOR ANTAGONISTS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-12-04 US disclosed
US-5360802-A Antagonists of cholecystokinin and gastrin MERCK SHARPE & DOHME LTD. 1994-11-01 US disclosed
EP-0514133-A1 Benzodiazepine derivatives, compositions containing them and their use in therapy MERCK SHARP & DOHME LTD. (GB) 1992-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140357655-A1 SPIROINDOLINE DERIVATIVES AS GONADOTROPIN- RELEASING HORMONE RECEPTOR ANTAGONISTS GNRHR, FSHR, NR5A1 ALDH1A1 1719/4885LMNA 314/4885KDM4E 2476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.